CoChat
Cited by 26

The DOI matches its Crossref record; the references it cites are not checked yet.

Cardioprotective effect of dexrazoxane during treatment with doxorubicin: A study using low‐dose dobutamine stress echocardiography

Paiva, Marcelo G., Petrilli, Antônio S., Moisés, Valdir A., Macedo, Carla Renata Donato, Tanaka, Cristiana, Campos, Orlando · 2005 · Pediatric Blood & Cancer

Abstract

Aim: To assess the late cardioprotective effect of dexrazoxane associated with doxorubicin during treatment of osteosarcoma by means of low‐dose dobutamine stress echocardiography (LDDSE) in non‐relapsed asymptomatic children and teenagers. Patients and Methods: The study population included 58 patients with osteosarcoma divided in three groups, with equivalent age range, gender proportion and body surface area. Group I (21 patients, 14 males, 15 ± 4 years) was analyzed before chemotherapy and considered the control group; Group II (19 patients, 11 males, 19.7 ± 4 years) was treated with 348.4 ± 18 mg/m 2 of doxorubicin only and Group III (18 patients, 14 male, 16.8 ± 5 years) treated with 396.5 ± 55 mg/m 2 of doxorubicin with dexrazoxane in the ratio 10:1. The patients were submitted to LDDSE (maximal dose 5 µg/kg/min). No major side effects were observed. Heart rate, blood pressure, left ventricular diameters, end systolic wall stress (ESWS), and other diastolic and systolic function indexes were assessed at rest conditions and during LDDSE and compared between the three groups. Results: Group III received a doxorubicin dose significantly greater than Group II (P = 0.001). During LDDSE there were no significant changes in the diastolic function indexes in any of the groups, but there was a significant increase of systolic indexes and a decrease of ESWS in Group III compared to group II. There was no significant difference of any systolic functional parameters between Group I and III. Considering the ejection fraction (EF) at rest or at LDDSE, 13 patients (69.4%) in Group II and 5 patients (27.7%) in Group III were considered to have systolic dysfunction. (P = 0.02). Conclusion: Myocardial response to LDDSE in patients treated with doxorubicin and dexrazoxane was similar to patients without chemotherapy and better than those treated with doxorubicin only, suggesting less cardiotoxicity. © 2005 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/pbc.20488

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

The citation lists haven’t been fetched yet

Cited by 26

Research works printed but not linked: 45

  1. 10.1056/NEJM199809243391307 · DOI · Paper page
  2. 10.1200/JCO.1997.15.4.1544 · DOI · Paper page
  3. 10.1053/ctrv.2000.0175 · DOI
  4. 10.1002/1097-0142(19830701)52:1<51::AID-CNCR2820520111>3.0.CO;2-# · doi:10.1002/1097-0142(19830701)52:1<51::aid-cncr2820520111>3.0.co;2-#
  5. 10.2165/00003495-199856030-00009 · DOI
  6. Hellmann K, 1996, Anthracycline cardiotoxicity prevention by dexrazoxane: Breakthrough of a barrier—sharpens antitumor profile and therapeutic index, J Clin Oncol, 14, 332, 10.1200/JCO.1996.14.2.332 · doi:10.1200/jco.1996.14.2.332
  7. 10.1200/JCO.1996.14.2.328 · doi:10.1200/jco.1996.14.2.328
  8. 10.1159/000227621 · DOI
  9. Stlinhertz LJ, 2001, Cardiac toxicity, 2739
  10. Fuster V, 1997, Hematology‐oncology and heart disease. Textbook of cardiovascular medicine, 1786
  11. Steinherz LJ, 1992, Guidelines for cardiac monitoring of children during and after anthracycline therapy: Report of the Cardiology Committee of thr Chidrens Cancer Study Group, Pediatrics, 89, 942, 10.1542/peds.89.5.942 · DOI · Paper page
  12. 10.1002/1097-0142(19931101)72:9<2739::AID-CNCR2820720935>3.0.CO;2-R · doi:10.1002/1097-0142(19931101)72:9<2739::aid-cncr2820720935>3.0.co;2-r
  13. 10.1016/S0002-9149(01)01476-X · doi:10.1016/s0002-9149(01)01476-x
  14. 10.1016/S0002-9149(00)01222-4 · doi:10.1016/s0002-9149(00)01222-4
  15. 10.1016/0002-8703(83)90651-8 · DOI
  16. 10.1016/0140-6736(91)92516-5 · doi:10.1016/0140-6736(91)92516-5
  17. 10.1016/S0002-8703(97)70205-9 · doi:10.1016/s0002-8703(97)70205-9
  18. 10.1007/BF02072099 · doi:10.1007/bf02072099
  19. 10.1016/S0002-8703(99)70468-0 · DOI
  20. 10.1002/1097-0142(19910715)68:2<435::AID-CNCR2820680237>3.0.CO;2-# · doi:10.1002/1097-0142(19910715)68:2<435::aid-cncr2820680237>3.0.co;2-#
  21. 10.1016/S0167-5273(97)00114-9 · DOI
  22. 10.1016/0735-1097(92)90497-B · DOI
  23. 10.1203/00006450-199603000-00020 · DOI
  24. 10.1016/S0002-9149(98)00008-3 · doi:10.1016/s0002-9149(98)00008-3
  25. Lenk MK, 1998, Detection of early anthracycline‐induced cardiotoxicity in childhood cancer with dobutamine stress echocardiography, Turk J Pediatr, 40, 373
  26. 10.1053/euje.2000.0037 · DOI
  27. Schwammmasthal E, 1998, Stress echocardiography beyond coronary artery disease, Eur Heart J, 17, D130
  28. 10.1056/NEJM199506293322602 · DOI · Paper page
  29. 10.1200/JCO.1998.16.2.545 · doi:10.1200/jco.1998.16.2.545
  30. 10.1007/BF01954271 · doi:10.1007/bf01954271
  31. 10.1136/hrt.73.4.340 · doi:10.1136/hrt.73.4.340
  32. 10.1016/0735-1097(92)90138-D · doi:10.1016/0735-1097(92)90138-d
  33. 10.1136/hrt.73.1.61 · DOI
  34. 10.1007/s002469900459 · DOI
  35. 10.1002/mpo.1135 · DOI
  36. 10.1016/S0002-9149(99)80254-9 · doi:10.1016/s0002-9149(99)80254-9
  37. 10.1007/BF02524797 · DOI
  38. 10.1067/mhj.2000.108237 · DOI
  39. 10.1016/0002-9149(94)90470-7 · DOI
  40. 10.1200/JCO.1998.16.1.86 · DOI
  41. Venturi M, 1996, Multicenter randomized contolled clinical trial to evaluated cardioprotection of dexrazoxane versus no cardioprotection in women receiving epirubicin chemotherapy for advanced breast cancer, J Clin Oncol, 14, 3112, 10.1200/JCO.1996.14.12.3112 · DOI · Paper page
  42. 10.1200/JCO.1997.15.4.1318 · DOI · Paper page
  43. 10.1056/NEJM198809223191203 · DOI · Paper page
  44. 10.1200/JCO.1996.14.2.362 · DOI · Paper page
  45. 10.1056/NEJMoa035153 · DOI · Paper page

Metadata

Authors
Paiva, M. G., Petrilli, A. S., Moisés, V. A., Macedo, C. R. D., Tanaka, C., & Campos, O.
Venue
Pediatric Blood & Cancer
Publisher
Wiley
Published
2005-07-20
Volume
45
Issue
7
Pages
902-908
ISSN
  • 1545-5009
  • 1545-5017
Cited by
26
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Cardioprotective effect of dexrazoxane during treatment with doxorubicin: A study using low‐dose dobutamine stress echocardiography. https://app.cochat.ai/papers/10.1002/pbc.20488
The paper
Paiva, M. G., Petrilli, A. S., Moisés, V. A., Macedo, C. R. D., Tanaka, C., & Campos, O. (2005). Cardioprotective effect of dexrazoxane during treatment with doxorubicin: A study using low‐dose dobutamine stress echocardiography. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.20488

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.